vs
Side-by-side financial comparison of SMARTFINANCIAL INC. (SMBK) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
SMARTFINANCIAL INC. is the larger business by last-quarter revenue ($53.8M vs $28.1M, roughly 1.9× ARS Pharmaceuticals, Inc.). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs -147.1%, a 172.5% gap on every dollar of revenue.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
SMBK vs SPRY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.8M | $28.1M |
| Net Profit | $13.7M | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | — | -147.6% |
| Net Margin | 25.4% | -147.1% |
| Revenue YoY | — | -67.6% |
| Net Profit YoY | 21.6% | -182.8% |
| EPS (diluted) | $0.81 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $53.8M | — | ||
| Q4 25 | $53.3M | $28.1M | ||
| Q3 25 | $51.1M | $32.5M | ||
| Q2 25 | $49.2M | $15.7M | ||
| Q1 25 | $46.8M | $8.0M | ||
| Q4 24 | $46.8M | $86.6M | ||
| Q3 24 | $44.2M | $2.1M | ||
| Q2 24 | $40.4M | $500.0K |
| Q1 26 | $13.7M | — | ||
| Q4 25 | $13.7M | $-41.3M | ||
| Q3 25 | $13.7M | $-51.2M | ||
| Q2 25 | $11.7M | $-44.9M | ||
| Q1 25 | $11.3M | $-33.9M | ||
| Q4 24 | $9.6M | $49.9M | ||
| Q3 24 | $9.1M | $-19.1M | ||
| Q2 24 | $8.0M | $-12.5M |
| Q1 26 | — | — | ||
| Q4 25 | 31.3% | -147.6% | ||
| Q3 25 | 33.2% | -163.7% | ||
| Q2 25 | 29.0% | -302.9% | ||
| Q1 25 | 29.0% | -466.3% | ||
| Q4 24 | 26.5% | 54.5% | ||
| Q3 24 | 24.3% | -1051.6% | ||
| Q2 24 | 25.6% | -3068.0% |
| Q1 26 | 25.4% | — | ||
| Q4 25 | 25.7% | -147.1% | ||
| Q3 25 | 26.8% | -157.4% | ||
| Q2 25 | 23.8% | -285.6% | ||
| Q1 25 | 24.0% | -425.7% | ||
| Q4 24 | 20.6% | 57.7% | ||
| Q3 24 | 20.7% | -925.0% | ||
| Q2 24 | 19.8% | -2503.2% |
| Q1 26 | $0.81 | — | ||
| Q4 25 | $0.81 | $-0.41 | ||
| Q3 25 | $0.81 | $-0.52 | ||
| Q2 25 | $0.69 | $-0.46 | ||
| Q1 25 | $0.67 | $-0.35 | ||
| Q4 24 | $0.57 | $0.52 | ||
| Q3 24 | $0.54 | $-0.20 | ||
| Q2 24 | $0.48 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $346.1M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $562.2M | $114.3M |
| Total Assets | $5.9B | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $346.1M | — | ||
| Q4 25 | $464.4M | $245.0M | ||
| Q3 25 | $557.1M | $288.2M | ||
| Q2 25 | $365.1M | $240.1M | ||
| Q1 25 | $423.0M | $275.7M | ||
| Q4 24 | $387.6M | $314.0M | ||
| Q3 24 | $192.9M | $204.6M | ||
| Q2 24 | $342.8M | $218.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $96.4M | ||
| Q3 25 | $1.3M | $96.2M | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $7.6M | — | ||
| Q4 24 | $8.1M | $0 | ||
| Q3 24 | $9.0M | — | ||
| Q2 24 | $12.7M | — |
| Q1 26 | $562.2M | — | ||
| Q4 25 | $552.4M | $114.3M | ||
| Q3 25 | $538.4M | $147.7M | ||
| Q2 25 | $519.0M | $192.3M | ||
| Q1 25 | $505.8M | $229.0M | ||
| Q4 24 | $491.3M | $256.8M | ||
| Q3 24 | $489.0M | $201.0M | ||
| Q2 24 | $472.5M | $215.2M |
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $327.7M | ||
| Q3 25 | $5.8B | $372.8M | ||
| Q2 25 | $5.5B | $313.5M | ||
| Q1 25 | $5.4B | $327.3M | ||
| Q4 24 | $5.3B | $351.2M | ||
| Q3 24 | $4.9B | $217.6M | ||
| Q2 24 | $4.9B | $222.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.84× | ||
| Q3 25 | 0.00× | 0.65× | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.02× | — | ||
| Q4 24 | 0.02× | 0.00× | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.03× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-43.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $61.7M | $-43.5M | ||
| Q3 25 | $16.9M | $-47.0M | ||
| Q2 25 | $14.0M | $-39.6M | ||
| Q1 25 | $14.3M | $-40.7M | ||
| Q4 24 | $52.7M | $42.0M | ||
| Q3 24 | $12.4M | $-14.5M | ||
| Q2 24 | $16.5M | $-7.3M |
| Q1 26 | — | — | ||
| Q4 25 | $59.3M | — | ||
| Q3 25 | $16.6M | $-47.2M | ||
| Q2 25 | $13.2M | $-39.6M | ||
| Q1 25 | $13.4M | $-40.8M | ||
| Q4 24 | $46.3M | $41.7M | ||
| Q3 24 | $11.3M | $-14.6M | ||
| Q2 24 | $15.4M | $-7.3M |
| Q1 26 | — | — | ||
| Q4 25 | 111.3% | — | ||
| Q3 25 | 32.4% | -145.4% | ||
| Q2 25 | 26.9% | -252.2% | ||
| Q1 25 | 28.5% | -512.1% | ||
| Q4 24 | 98.9% | 48.2% | ||
| Q3 24 | 25.7% | -706.3% | ||
| Q2 24 | 38.2% | -1463.4% |
| Q1 26 | — | — | ||
| Q4 25 | 4.5% | 0.0% | ||
| Q3 25 | 0.6% | 0.6% | ||
| Q2 25 | 1.6% | 0.3% | ||
| Q1 25 | 2.0% | 1.1% | ||
| Q4 24 | 13.7% | 0.3% | ||
| Q3 24 | 2.4% | 6.8% | ||
| Q2 24 | 2.7% | 7.6% |
| Q1 26 | — | — | ||
| Q4 25 | 4.50× | — | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | 5.47× | 0.84× | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 2.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
